Farrah B Khan MD
Assistant Professor, Medicine, University of Vermont College of Medicine
Join to view full profile
111 Colchester AveVermont Cancer CentreBurlington, VT 05401
Phone+1 802-656-5456
Dr. Khan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Boston Medical Center-BrightonResidency, Internal Medicine, 2003 - 2006
Royal College of Surgeons IrelandClass of 2003
Certifications & Licensure
VT State Medical License 2007 - 2026
MA State Medical License 2006 - 2018
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
- A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Publications & Presentations
PubMed
- Patient-specific pharmacokinetics of intratumoral cisplatin track pathologic necrosis in early-stage lung cancer.Vitor Mori, Hannah Kooperkamp, Farrah Khan, Kelly Butnor, Pamela Gibson
Journal of Controlled Release. 2026-10-22 - 5 citationsInitial Safety and Feasibility Results From a Phase 1, Diagnose-and-Treat Trial of Neoadjuvant Intratumoral Cisplatin for Stage IV NSCLC.Farrah B Khan, Pamela C Gibson, Scott Anderson, Sarah Wagner, Bernard F Cole
JTO Clinical and Research Reports. 2024-03-01 - 5 citationsEndobronchial ultrasound-guided transbronchial needle injection of cisplatin results in dynamic changes in the tumor immune microenvironment.Emily A DuComb, Cheryl C Collins, Dolores Cupak, Sarah Wagner, Farrah B Khan
Respiratory Medicine and Research. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: